U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(43)
(66)
(184)
(228)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(404)
(96)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(42)
(62)
(187)
(221)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(411)
(90)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(160)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(163)
(164)
(156)
(164)
(156)
(173)
(141)
(155)
(159)
(134)
(156)
(141)
(142)
(140)
(137)
(138)
(142)
(131)
(162)
(143)
(136)
(152)
(152)
(177)
(206)
(197)
(164)
(187)
(179)
(201)
(205)
(202)
(221)
(225)
(231)
(221)
(225)
(252)
(252)
(277)
0 of 56
(2)
(1)
(4)
(431)
(107)
(404)
(13)
(8542)
0 of 8
(16)
(34)
(37)
(1)
(1)
(2)
(6)
(1)
0 of 8
(10)
(10)
(25)
(11)
(7)
(20)
(27)
(42)
(58)
(7)
(23)
(13)
(7)
(38)
(10)
(10)
(50)
(7)
(33)
(1236)
(23)
(1293)
(32)
(71)
(10)
(91)
(26)
(16)
(7)
(791)
(198)
(24)
(128)
(70)
(39)
(61)
(10)
(9)
(11)
(17)
(20)
(38)
(19)
(26)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(48)
(11)
(8)
(223)
(17)
(17)
(8)
(181)
(137)
(129)
(32)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(29)
(17)
(10)
(7)
(18)
(100)
(13)
(12)
(36)
(18)
(8)
(12)
(7)
(11)
(11)
(30)
(9)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(10)
(61)
(7)
(7)
(14)
(12)
(13)
(15)
(19)
(85)
(13)
(11)
(14)
(31)
(14)
(13)
(30)
(28)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(7)
(17)
(22)
(20)
(7)
(14)
(10)
(9)
(24)
(13)
(31)
(20)
(29)
(7)
(13)
(13)
(31)
(73)
(10)
(21)
(24)
(8)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(940)
(740)
(9)
(14)
(7)
(14)
(35)
(7)
(7)
(103)
(10)
(51)
(10)
(19)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(80)
(2976)
(37)
(12)
(546)
(316)
(257)
(215)
(24)
(38)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(28)
(446)
(21)
(23)
(15)
(8)
(74)
(25)
(19)
(9)
(18)
(18)
(18)
(45)
(687)
(8)
(10)
(15)
(59)
(205)
(7)
(10)
(18)
(8)
(12)
(66)
(24)
(14)
(40)
(73)
(8)
(11)
(8)
(11)
(20)
(19)
(23)
(58)
(9)
(8)
(16)
(33)
(44)
(82)
(9)
(10)
(8)
(21)
(65)
(8)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(24)
(14)
(35)
(26)
(9)
(11)
(9)
(24)
(26)
(12)
(92)
(4165)
(636)
(34)
(12)
(17)
(10)
(14)
(11)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(8)
(12)
(27)
(17)
(14)
(44)
(20)
(28)
(36)
(10)
(20)
(8)
(21)
(8)
(66)
(91)
(24)
(9)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(67)
(21)
(15)
(149)
(8)
(12)
(32)
(16)
(14)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(32)
(15)
(654)
(51)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(8)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(14)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(25)
(186)
(14)
(42)
(45)
(25)
(47)
(13)
(16)
(11)
(593)
(394)
(15)
(21)
(14)
(152)
(15)
(53)
(9)
(28)
(10)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(52)
(68)
(59)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(69)
(116)
(29)
(172)
(25)
(17)
(50)
(12)
(10)
(33)
(12)
(10)
(45)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(19)
(159)
(10)
(14)
(31)
(8)
(8)
(9)
(9)
(12)
(28)
(51)
(9)
(206)
(18)
(31)
(17)
(19)
(2445)
(16)
(18)
(18)
(11)
(104)
(20)
(38)
(8)
(206)
(231)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(10)
(307)
(15)
(47)
(61)
(23)
(17)
(8)
(21)
(595)
(13)
(61)
(15)
(14)
(9)
(37)
(26)
(22)
(29)
(188)
(45)
(54)
(48)
(8)
(114)
(50)
(10)
(125)
(28)
(11)
(12)
(8)
(32)
(22)
(8)
(12)
(22)
(13)
(61)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(177)
(17)
(12)
(14)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(308)
(40)
(33)
(23)
(11)
(12)
(9)
(83)
(11)
(12)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(12)
(8)
(10)
(57)
(3828)
(11)
(9)
(9)
(31)
(16)
(21)
(16)
(16)
(15)
(17)
(10)
(13)
(8)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(8)
(36)
(14)
(113)
(10)
(257)
(611)
(72)
(11)
(21)
(17)
(8)
(11)
(15)
(9)
(10)
(299)
(12)
(10)
(8)
(14)
(11)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(10)
(22)
(10)
(64)
(10)
(9)
(10)
(9)
(9)
(19)
(12)
(9)
(144)
(18)
(14)
(8)
(33)
(144)
(11)
(171)
(10)
(8)
(8)
(22)
(70)
(343)
(114)
(84)
(24)
(36)
(34)
(11)
(30)
(14)
(8)
(10)
(25)
(21)
(29)
(21)
(18)
(16)
(1138)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(10)
(18)
(72)
(16)
(15)
(26)
(14)
(27)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1001)
(22)
(24)
(71)
(101)
(2516)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(279)
(15)
(8)
(9)
(13)
(45)
(32)
(91)
(9)
(17)
(18)
(16)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(67)
(195)
(303)
(8)
(14)
(11)
(21)
(12)
(8)
(58)
(17)
(34)
(9)
(38)
(617)
(31)
(32)
(146)
(241)
(12)
(177)
(10)
(18)
(10)
(122)
(8)
(11)
(126)
(9)
(16)
(18)
(15)
(19)
(11)
(9)
(19)
(11)
(28)
(35)
(38)
(11)
(8)
(65)
(22)
(16)
(40)
(28)
(10)
(14)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(9)
(28)
(23)
(70)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(9)
(8)
(12)
(18)
(94)
(35)
(31)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(182)
(10)
(8)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(8)
(54)
(15)
(12)
(8)
(15)
(8)
(10)
(58)
(19)
(181)
(28)
(36)
(22)
(106)
(19)
(157)
(13)
(9)
(12)
(15)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(70)
(18)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(464)
(11)
(48)
(49)
(104)
(17)
(102)
(29)
(25)
(34)
(21)
(40)
(8)
(10)
(23)
(31)
(20)
(35)
(21)
(12)
(18)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(15)
(78)
(8)
(10)
(43)
(13)
(15)
(46)
(27)
(763)
(30)
(57)
(10)
(12)
(29)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(12)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(8)
(15)
(8)
(8)
(13)
(28)
(7)
(18)
(8)
(12)
(15)
(7)
(7)
(17)
(17)
(8)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(17)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(25)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(20)
(9)
(15)
(7)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(7)
(19)
(8)
(10)
(10)
(8)
(10)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(11)
(22)
(7)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(14)
(35)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(32)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(11)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
0 of 1000
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(13)
(1)
(1)
(7)
(1)
(16)
(14)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(4)
(1)
(3)
(6)
(5)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(6)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(111)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3939)
(6)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(65)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(21)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(425)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(5)
(1)
(2)
(3)
(2)
(3)
(9)
(2)
(2)
(2)
(2)
(9)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(12)
(2)
(7)
(4)
(2)
(3)
(2)
(3)
(4)
(4)
(2)
(5)
(7)
(4)
(2)
(5)
(7)
(2)
(9)
(2)
(2)
(8)
(2)
(2)
(2)
(4)
(9)
(3)
(3)
(2)
(2)
(5)
(9)
(4)
(4)
(2)
(2)
(5)
(4)
(2)
(3)
(3)
(9)
(4)
(4)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(11)
(2)
(3)
(2)
(2)
(2)
(3)
(10)
(4)
(2)
(8)
(2)
(15)
(2)
(2)
(20)
(2)
(3)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(3)
(2)
(2)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(2)
(5)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(149)
(7)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(3)
(2)
(4)
(15)
(3)
(4)
(3)
(8)
(15)
(6)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(6)
(3)
(3)
(2)
(3)
(2)
(10)
(12)
(4)
(2)
(3)
(3)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(13)
(2)
(4)
(2)
(2)
(2)
(4)
(3)
(9)
(2)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(4)
(3)
(3)
(3)
(4)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(2)
(14)
(7)
(7)
(3)
(2)
(3)
(2)
(2)
(2)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(6)
(93)
(2)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(4)
(3)
(6)
(2)
(3)
(4)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(3)
(3)
(2)
(14)
(2)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(2)
(5)
(8)
(2)
(4)
(2)
(3)
(2)
(3)
(7)
(2)
(2)
(4)
(4)
(2)
(4)
(2)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(113)
(2)
(8)
(1)
(2910)
(5)
(2017)
(13)
(35)
(84)
(3)
(1)
(1)
(2)
(4)
(14)
(1)
(53)
(4069)
(2)
(4)
0 of 23
(1)
(2)
(15)
(33)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(7)
(2)
(180)
(1)
(113)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(2)
(23)
(2)
(1)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(16)
(1)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(1)
(14)
(3)
(53)
(1)
(4)
(1)
(1)
(1)
(8)
(16)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(14)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(1)
(1)
(4)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(315)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(3)
(12)
(5)
(1)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(3)
(76)
(1)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(96)
(1)
(1)
(2)
(4)
(5)
(209)
(1)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(3)
(1)
(1)
(1)
(3)
(1)
(306)
(3)
(1)
(131)
(2)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(2)
(1)
(1)
(3)
(1)
(18)
(1)
(5)
(3)
(3)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(1)
(6)
(2)
(16)
(1)
(7)
(5)
(156)
(1)
(1)
(1)
(6)
(3)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(1)
(45)
(1)
(2)
(4)
(10)
(8)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(57)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(72)
(1)
(1)
(1)
(1)
(1)
(3)
(6)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(300)
(1)
(1)
(13)
(10)
(2)
(27)
(1)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(116)
(46)
(8)
(2)
(1)
(4)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(24)
(1)
(1)
(67)
(7017)
(1)
(11)
(1)
(1)
(5)
(11)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(31)
(3)
(1)
(4)
(215)
(4)
(2)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
0 of 772
(1)
(55)
(9)
(2)
(2)
(25)
(294)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(61)
(10)
(1)
(2)
(5)
(1)
(729)
(2)
(2773)
(5)
(5)
(37)
(1)
(15)
(1)
(7)
(3)
(16)
(27)
(1)
(108)
(2)
(383)
(52)
(1)
(1)
(1)
(1)
(2026)
(1)
(5)
(1)
(8)
(362)
(4)
(3)
(50)
(3)
0 of 56
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 521 - 540 of 9530 results
  • MMWR Morbidity and Mortality Weekly Report Vol 72 No 5253 January 5 2023
    MMWR. Morbidity and Mortality Weekly Report, Vol. 72, No. 52-53, January 5, 2023
    Centers for Disease Control and Prevention (U.S.)
    January 5, 2023  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells — United States, 2023Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months — California, January–March, 2023Notes from the Field: Seizures, Hyperthermia, and Myocardial Injury in Three ...
    Public Domain
  • QuickStats Percentage of Emergency Department Visits for Pain At Which Opioids Were Given Or Prescribed by Patient Age and Year National Hospital Ambulatory Medical Care Survey United States 20102020
    QuickStats: Percentage of Emergency Department Visits for Pain At Which Opioids Were Given Or Prescribed, by Patient Age and Year — National Hospital Ambulatory Medical Care Survey, United States, 2010–2020
    National Center for Health Statistics (U.S.)
    12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID19Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults VISION Network Nine States SeptemberNovember 2022
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
    Tenforde, Mark W. ;
    Weber, Zachary A.
    12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During June-October 2022, the SARS-CoV-2 Omicron BA.5 sublineage accounted for most of the sequenced viral genomes in the United States, with further Omicron sublineage diversification through November 2022.* Bivalent mRNA vaccines contain an ancestral SARS-CoV-2 strain component plus an updated component of the Omicron BA.4/BA.5 sublineages. On Se ...
    Supporting Files Public Domain
  • Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID19Associated Hospitalization Among Immunocompetent Adults Aged 65 Years IVY Network 18 States September 8November 30 2022
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
    Surie, Diya ;
    DeCuir, Jennifer
    12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Monovalent COVID-19 mRNA vaccines, designed against the ancestral strain of SARS-CoV-2, successfully reduced COVID-19-related morbidity and mortality in the United States and globally (1,2). However, vaccine effectiveness (VE) against COVID-19-associated hospitalization has declined over time, likely related to a combination of factors, including w ...
    Supporting Files Public Domain
  • Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons 29 US Jurisdictions May 22September 3 2022
    Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022
    Farrar, Jennifer L. ;
    Lewis, Nathaniel M.
    12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    As of November 14, 2022, monkeypox (mpox) cases had been reported from more than 110 countries, including 29,133 cases in the United States.* Among U.S. cases to date, 95% have occurred among males (1). After the first confirmed U.S. mpox case on May 17, 2022, limited supplies of JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) w ...
    Supporting Files Public Domain
  • Epidemiologic and Clinical Features of Mpox in Transgender and GenderDiverse Adults United States MayNovember 2022
    Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults — United States, May–November 2022
    Blackburn, Dawn ;
    Roth, Nicole M.
    12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    As of November 9, 2022, a total of 28,730 cases of monkeypox (mpox) had been reported in the United States,* primarily among adult cisgender men reporting recent male-to-male sexual contact (1). Transgender and gender-diverse persons, who constitute an estimated 0.5% of the U.S. adult population,| face unique health disparities and barriers to care ...
    Supporting Files Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 71 Nos 51 52 December 30 2022
    MMWR. Morbidity and Mortality Weekly Report, Vol. 71, Nos. 51 & 52, December 30, 2022
    Centers for Disease Control and Prevention (U.S.)
    December 30, 2022  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults — United States, May–November 2022 / Dawn Blackburn; Nicole M. Roth; Jeremy A.W. Gold; Leah Zilversmit Pao et al. --Demographic and Clinical Characteristics of Mpox in Persons Who Previously Received 1 Dose of JYNNEOS Vaccine Compared with Mpox in Unvaccinated Pers ...
    Public Domain
  • Notes From the Field Clinical and Epidemiologic Characteristics of Mpox Cases From the Initial Phase of the Outbreak New York City May 19July 15 2022
    Notes From the Field: Clinical and Epidemiologic Characteristics of Mpox Cases From the Initial Phase of the Outbreak — New York City, May 19–July 15, 2022
    Kyaw, Nang Thu Thu ;
    Kipperman, Naama
    12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Drug Overdose Deaths Among Persons Aged 1019 Years United States July 2019December 2021
    Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021
    Tanz, Lauren J. ;
    Dinwiddie, Amanda T.
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    U.S. drug overdose deaths increased 30% from 2019 to 2020 and 15% in 2021, resulting in an estimated 108,000 deaths in 2021.* Among persons aged 14-18 years, overdose deaths increased 94% from 2019 to 2020 and 20% from 2020 to 2021 (1), although illicit drug use declined overall among surveyed middle and high school students during 2019-2020 (2). W ...
    Supporting Files Public Domain
  • Erratum Vol 71 No 45
    Erratum: Vol. 71, No. 45
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    cdc:123145Vol. 71, No. 45 In the report “COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022,” on page 1442, the fifth sentence of the first paragraph should have read, “During the Omicron BA.2/BA.5–predominant periods (March 20– August 31, 2022), weekly hospitalizations per 100,000 infants aged <6 months increased from a nadir of 2.2 (week ending April 9, 2022) to a peak of 26.0 (week ending July 23, 2022), and the average weekly hospitalization rate among these infants (13.7) was similar to that among adults aged 65–74 years (13.8).” In addition, on page 1443, the last sentence of the fourth paragraph should have read, “The mean weekly hospitalization rate among infants aged <6 months during the Omicron BA.2/BA.5 period (13.7) was less than that of adults aged ≥75 years (39.4), similar to that of adults aged 65–74 years (13.8) and higher than rates in all other pediatric age groups (2.3 and 0.8 for children aged 6 months–4 years and 5–17 years, respectively) and in adults aged <65 years (4.6).”
    Supporting Files Public Domain
  • COVID19 and Other Underlying Causes of Cancer Deaths United States January 2018July 2022
    COVID-19 and Other Underlying Causes of Cancer Deaths — United States, January 2018–July 2022
    Henley, S. Jane ;
    Dowling, Nicole F.
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Cancer survivors (persons who have received a diagnosis of cancer, from the time of diagnosis throughout their lifespan)* have increased risk for severe COVID-19 illness and mortality (1). This report describes characteristics of deaths reported to CDC's National Vital Statistics System (NVSS), for which cancer was listed as the underlying or a con ...
    Supporting Files Public Domain
  • Prevalence of SARSCoV2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged 18 Years Who Were Hospitalized or Died with Influenza United States 202122 Influenza Season
    Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season
    Adams, Katherine ;
    Tastad, Katie J.
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The 2022-23 influenza season shows an early rise in pediatric influenza-associated hospitalizations (1). SARS-CoV-2 viruses also continue to circulate (2). The current influenza season is the first with substantial co-circulation of influenza viruses and SARS-CoV-2 (3). Although both seasonal influenza viruses and SARS-CoV-2 can contribute to subst ...
    Supporting Files Public Domain
  • Erratum Vol 71 No 40
    Erratum: Vol. 71, No 40
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    cdc:Corrects: MMWR Morb Mortal Wkly Rep. 2022 Oct 7; 71(40): 1288–1290.Vol. 71, No. 40 In the report, “Notes from the Field: Coagulopathy Associated with Brodifacoum Poisoning 2014 — Florida, December 2021,” on page 1288, the second sentence of the third paragraph should have read, “Five patients provided the SCB products they had smoked for analys ...
    Supporting Files Public Domain
  • Progress Toward Measles and Rubella Elimination India 20052021
    Progress Toward Measles and Rubella Elimination — India, 2005–2021
    Murugan, Ratnesh ;
    VanderEnde, Kristin
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In 2019, India, along with other countries in the World Health Organization (WHO) South-East Asia Region,* adopted the goal of measles and rubella elimination by 2023,| a revision of the previous goal of measles elimination and control of rubella and congenital rubella syndrome (CRS) by 2020| (1-3). During 2017-2021, India adopted a national strate ...
    Supporting Files Public Domain
  • QuickStats Birth Rates for Females Aged 1519 Years by State National Vital Statistics System United States 2021
    QuickStats: Birth Rates for Females Aged 15–19 Years, by State — National Vital Statistics System, United States, 2021
    Hamilton, Brady E.
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In 2021, the U.S. birth rate for females aged 15–19 years was 13.9 births per 1,000 persons, with rates generally lower in the Northeast and higher across the southern states. Birth rates among females aged 15–19 years ranged from 5.4 in New Hampshire, 5.7 in Massachusetts, and 6.4 in Vermont to 26.5 in Arkansas and 25.6 in Mississippi.Source: Nati ...
    Supporting Files Public Domain
  • Notes From the Field Burkholderia Pseudomallei Detected in a Raccoon Carcass Linked to a Multistate AromatherapyAssociated Melioidosis Outbreak Texas 2022
    Notes From the Field: Burkholderia Pseudomallei Detected in a Raccoon Carcass Linked to a Multistate Aromatherapy-Associated Melioidosis Outbreak — Texas, 2022
    Petras, Julia K. ;
    Elrod, Mindy G.
    12 16 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Supplementary Table Number and Percentage of Cancer Deaths Cancer as a Contributing or Underlying Cause of Death by Underlying Cause of Death and MMWR Week of Death United States 20182022
    Supplementary Table. Number and Percentage of Cancer Deaths (Cancer as a Contributing or Underlying Cause of Death) by Underlying Cause of Death§ and MMWR Week of Death — United States, 2018–2022
    Centers for Disease Control and Prevention (U.S.)
    December 16, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 71 December 16 2022
    MMWR. Morbidity and Mortality Weekly Report, Vol. 71, December 16, 2022
    Centers for Disease Control and Prevention (U.S.)
    12/16/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Progress Toward Measles and Rubella Elimination — India, 2005–2021 / Ratnesh Murugan; Kristin VanderEnde; Veena Dhawan; Pradeep Haldar et al. -- Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021 / Lauren J. Tanz; Amanda T. Dinwiddie; Christine L. Mattson; Julie O’Donnell etal. -- COVID-19 and Other Underly ...
    Public Domain
  • Morbidity and Mortality Weekly Report MMWR Recommendations and Reports Vol 71 No 4 December 16 2022
    Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports / Vol. 71 / No. 4, December 16, 2022
    Melgar, Michael ;
    Lee, Ellen H.
    12/16/2022 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Since May 14, 2020, CDC has conducted national surveillance for multisystem inflammatory syndrome in children (MIS-C) associated with infection with SARS-CoV-2, the virus that causes COVID-19, among persons aged <21 years using a CDC case definition based on public health need and data from early reports of patients with this condition. Recent analyses of accumulated data indicated that certain criteria from the 2020 CDC MIS-C case definition performed better than others in distinguishing MIS-C from other illnesses and that certain other criteria likely contributed to misclassification. To incorporate lessons learned from MIS-C surveillance and public health investigations and to improve feasibility of implementation by surveillance staff at state, local, territorial, and tribal health departments, the Council of State and Territorial Epidemiologists (CSTE) and CDC developed a CSTE/CDC position statement (approved by CSTE in 2022) that includes an MIS-C surveillance case definition for voluntary reporting to CDC (effective January 1, 2023)This report summarizes the evidence and rationale supporting the components of the CSTE/CDC MIS-C surveillance case definition and describes the methods used to develop the definition. These methods included convening MIS-C clinical experts (i.e., consultants)regarding identification of MIS-C and its distinction from other pediatric conditions, a review of available literature comparing MIS-C phenotype with that of pediatric COVID-19 and other hyperinflammatory syndromes, and retrospective application of different criteria to data from MIS-C cases previously reported to CDC.The CSTE/CDC surveillance case definition for MIS-C includes four important changes, in comparison with the 2020 CDC MIS-C case definition. These changes are 1) no required duration of subjective or measured fever; 2) requirement of C-reactive protein ≥3.0 mg/dL to indicate systemic inflammation; 3) adjustments to criteria of organ system involvement to include addition of shock as a separate category and elimination of respiratory, neurologic, and renal criteria; and 4) new requirements on timing of positive SARS-CoV-2 laboratory testing relative to the MIS-C illness. Although MIS-C is not a nationally notifiable condition and reporting is voluntary, CSTE and CDC recommend that all states and territories report all cases meeting confirmed, probable, or suspect criteria of the CSTE/CDC MIS-C surveillance case definition beginning January 1, 2023, for cases with MIS-C illness onset on or after that date
    Supporting Files Public Domain
  • Council of State and Territorial EpidemiologistsCDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARSCoV2 Infection United States 2 Supplementary Tables
    Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States [2 Supplementary Tables]
    Melgar, Michael ;
    Lee, Ellen H.
    12/16/2022 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Supplementary Table 1. World Health Organization (WHO), Brighton Collaboration, and Royal College of Paediatrics and Child Health (RCPCH) case definitions for Multisystem Inflammatory Syndrome in Children (MIS-C) or Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19 (PIMS-TS).Supplementary Table 2. Side-by-side compari ...
    Public Domain
521 - 540 / 9530
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov